Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bitwise MARA Option Income Strategy ETF

48.43
-0.3900-0.80%
Pre-market: 48.990.5700+1.18%08:45 EDT
Volume:35.87K
Turnover:1.75M
Market Cap:11.14M
PE:- -
High:49.71
Open:49.71
Low:48.15
Close:48.82
Loading ...

Company Profile

Company Name:
Bitwise MARA Option Income Strategy ETF
Exchange:
AMEX
Establishment Date:
2025
Employees:
- -
Office Location:
250 Montgomery Street,Suite 200,San Francisco,California,United States
Zip Code:
94104
Fax:
- -
Introduction:
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.